# A Study to Assess S-309309 in Healthy and Obese Participants

> **NCT05247970** · PHASE1 · COMPLETED · sponsor: **Shionogi** · enrollment: 74 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** S-309309
- **DRUG:** Midazolam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05247970
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-04
- **Primary completion:** 2022-10-20
- **Final completion:** 2022-11-01
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2023-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05247970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05247970, "A Study to Assess S-309309 in Healthy and Obese Participants". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05247970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*